Related Experiment Video
Updated: Jan 17, 2026

Fluorescence Assays for the Study of Mycobacterium tuberculosis Interaction with the Immune Receptor SLAMF1
Published on: February 28, 2025
Cell death mechanisms during Mycobacterium tuberculosis infection: A perspective from a host-pathogen interface
Prachi Nangpal1, Nupur Angrish1, Garima Khare1
1Department of Biochemistry, University of Delhi South Campus, New Delhi, India.
Mycobacterium tuberculosis (Mtb) evades host immunity by inhibiting cell death pathways. Understanding these host-pathogen interactions is key to developing new host-directed therapies for tuberculosis.
Area of Science:
- Immunology
- Microbiology
- Cell Biology
Background:
- Tuberculosis (TB), caused by Mycobacterium tuberculosis (Mtb), is a significant global health threat.
- Mtb is an intracellular pathogen that employs sophisticated mechanisms to evade host immune responses.
- Cell death pathways, including apoptosis, pyroptosis, necroptosis, and autophagy, are crucial for controlling intracellular pathogens like Mtb.
Purpose of the Study:
- To explore the role of various cell death modalities in anti-TB immunity.
- To investigate how Mtb inhibits host cell death pathways as a virulence strategy.
- To highlight the potential of host-directed therapies (HDTs) for TB treatment.
Main Methods:
- Review of existing literature on Mtb-host interactions and cell death pathways.
- Analysis of Mtb's mechanisms for subverting host immunity.
- Exploration of signaling cascades involved in cell death and Mtb infection.
Main Results:
- Mtb actively inhibits host cell death processes to ensure its survival and replication.
- Dysregulation of cell death pathways by Mtb contributes to persistent infection and pathogenesis.
- Targeting host cell death pathways offers a promising avenue for novel therapeutic strategies.
Conclusions:
- Understanding Mtb's manipulation of host cell death is crucial for advancing TB research.
- Host-directed therapies modulating cell death offer a complementary approach to traditional anti-TB drugs.
- Further research into host-pathogen interactions at the cellular level will facilitate the design of effective HDTs for tuberculosis.
More Related Videos
09:34An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis
Published on: August 16, 2021
06:49Visualization of Macrophage Lytic Cell Death During Mycobacterial Infection in Zebrafish Embryos via Intravital Microscopy
Published on: January 9, 2019
Related Concept Videos
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Defense Against Bacterial Pathogens
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Cell-mediated Immune Responses
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Overview of Cell Death
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the...